The contradicting effects of SHP-1 in AML in vitro and the lack of significant findings in vivo indicate a lack of understanding of SHP-1 signaling pathways and mechanisms involving AML pathogenesis. The gene discussed is PTPN6; the disease is acute myeloid leukemia.